Curaleaf Holdings Statistics
Total Valuation
TSX:CURA has a market cap or net worth of CAD 2.47 billion. The enterprise value is 3.87 billion.
| Market Cap | 2.47B |
| Enterprise Value | 3.87B |
Important Dates
The last earnings date was Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CURA has 774.34 million shares outstanding. The number of shares has increased by 2.87% in one year.
| Current Share Class | 680.37M |
| Shares Outstanding | 774.34M |
| Shares Change (YoY) | +2.87% |
| Shares Change (QoQ) | -1.59% |
| Owned by Insiders (%) | 5.95% |
| Owned by Institutions (%) | 3.07% |
| Float | 628.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.42 |
| PB Ratio | 2.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.26 |
| P/OCF Ratio | 13.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.97, with an EV/FCF ratio of 37.99.
| EV / Earnings | -12.21 |
| EV / Sales | 2.22 |
| EV / EBITDA | 9.97 |
| EV / EBIT | 110.85 |
| EV / FCF | 37.99 |
Financial Position
The company has a current ratio of 1.52, with a Debt / Equity ratio of 1.23.
| Current Ratio | 1.52 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.23 |
| Debt / EBITDA | 3.67 |
| Debt / FCF | 13.96 |
| Interest Coverage | 0.25 |
Financial Efficiency
Return on equity (ROE) is -22.02% and return on invested capital (ROIC) is 1.42%.
| Return on Equity (ROE) | -22.02% |
| Return on Assets (ROA) | 0.55% |
| Return on Invested Capital (ROIC) | 1.42% |
| Return on Capital Employed (ROCE) | 1.00% |
| Weighted Average Cost of Capital (WACC) | 10.52% |
| Revenue Per Employee | 315,051 |
| Profits Per Employee | -57,406 |
| Employee Count | 5,519 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.86 |
Taxes
In the past 12 months, TSX:CURA has paid 169.59 million in taxes.
| Income Tax | 169.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.78% in the last 52 weeks. The beta is 1.44, so TSX:CURA's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | +68.78% |
| 50-Day Moving Average | 3.56 |
| 200-Day Moving Average | 3.02 |
| Relative Strength Index (RSI) | 46.31 |
| Average Volume (20 Days) | 591,272 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CURA had revenue of CAD 1.74 billion and -316.82 million in losses. Loss per share was -0.49.
| Revenue | 1.74B |
| Gross Profit | 865.21M |
| Operating Income | 34.90M |
| Pretax Income | -107.24M |
| Net Income | -316.82M |
| EBITDA | 304.47M |
| EBIT | 34.90M |
| Loss Per Share | -0.49 |
Balance Sheet
The company has 139.27 million in cash and 1.42 billion in debt, with a net cash position of -1.28 billion or -1.66 per share.
| Cash & Cash Equivalents | 139.27M |
| Total Debt | 1.42B |
| Net Cash | -1.28B |
| Net Cash Per Share | -1.66 |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 1.34 |
| Working Capital | 211.58M |
Cash Flow
In the last 12 months, operating cash flow was 188.81 million and capital expenditures -86.98 million, giving a free cash flow of 101.83 million.
| Operating Cash Flow | 188.81M |
| Capital Expenditures | -86.98M |
| Free Cash Flow | 101.83M |
| FCF Per Share | 0.13 |
Margins
Gross margin is 49.76%, with operating and profit margins of 2.01% and -18.22%.
| Gross Margin | 49.76% |
| Operating Margin | 2.01% |
| Pretax Margin | -6.17% |
| Profit Margin | -18.22% |
| EBITDA Margin | 17.51% |
| EBIT Margin | 2.01% |
| FCF Margin | 5.86% |
Dividends & Yields
TSX:CURA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.87% |
| Shareholder Yield | -2.87% |
| Earnings Yield | -12.83% |
| FCF Yield | 4.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |